Search for: "SCHERING CORPORATION" Results 81 - 100 of 136
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2009, 8:39 am by SOIssues
Child AbuseWatch CEO, Evin Daly, wrote to Roger Goodell, the NFL's Executive Vice President copying a line up of senior executives and CBS's Leslie Moonves, President and Chief Executive Officer, CBS Corporation and Peter Dunn, President, CBS Television Stations. [read post]
8 Jan 2010, 12:43 am
Defendants are embracing this strategy in the face of shrinking corporate legal budgets, and the united front can also pose a more powerful force in court or at the negotiating table. [read post]
22 Apr 2012, 12:07 pm
Organon is part of the Schering-Plough Corporation, which is now owned by Merck. [read post]
18 Mar 2013, 4:23 am by Dennis Crouch
The act of marking is akin to a corporate officer admitting in a letter or at a deposition that the company's product infringes a patent. [read post]
29 May 2009, 4:58 am
Soliciting Shareholder Feedback on Compensation Practices - Taking a page from Schering-Plough's efforts to survey investors about pay practices, Amgen is inviting its shareholders to offer comments on TIAA-CREF's "Ten Questions for Evaluating CD&As. [read post]
24 Apr 2007, 1:04 am
The firm announced its "strategic alliance" with Gray Haile, a minority-owned corporate law boutique based in Washington, D.C. [read post]
17 Jan 2007, 8:11 am
In addition, Walt Disney, First Data, Schering-Plough, and Zimmer Holdings have agreed to adopt majority voting in response to proposals from the Sheet Metal Workers International Association (SMWIA). [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
15 Jan 2010, 10:49 am by Joshua Kubicki
This means looking at "the facts and the law and the witnesses and the documents" according to PD Villarreal, the head of litigation for Schering-Plough. [read post]
25 Apr 2012, 1:56 pm by Jeffrey May
The FTC’s brief urges the Third Circuit to reverse a decision of the federal district court in New Jersey granting summary judgment ((CCH) 2010-1 Trade Cases ¶76,949) in favor of the patent holder, Schering-Plough Corporation, and the alleged infringers–Upsher Smith and ESI. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
29 Jun 2010, 6:01 pm by Duncan
(Patent Docs) Zetia (Ezetimibe) – US: Patent infringement complaint filed following a Paragraph IV certification: Schering Corporation et al. v. [read post]
30 Jun 2010, 5:52 am
(Patent Docs) Zetia (Ezetimibe) – US: Patent infringement complaint filed following a Paragraph IV certification: Schering Corporation et al. v. [read post]
15 Sep 2010, 2:40 am by Kelly
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin; alleges that FDA… [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]